M17, a Gene Specific for Germinal Center (GC) B Cells and a Prognostic Marker for GC B-cell Lymphomas, is Dispensable for the GC Reaction in Mice

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2006 Feb 24

PMID 16493007

Citations 14

Authors

Dominik Schenten

Angela Egert

Manolis Pasparakis

Klaus Rajewsky

Affiliations

Soon will be listed here.

Abstract

In T-cell-dependent antibody responses, antigen-specific B cells undergo a phase of secondary antibody diversification in germinal centers (GCs). Somatic hypermutation (SHM) introduces mutations into the rearranged immunoglobulin (Ig) variable (V) region genes, and class-switch recombination (CSR) alters the Ig heavy (H) chain constant region. Aberrant SHM or CSR is thought to contribute to the development of GC-derived B-cell malignancies. Diffuse large B-cell lymphomas (DLBCLs) are a heterogeneous group of such GC-derived tumors. Based on their gene expression profile, DLBCLs can be divided into activated B-cell-like and GC-like subgroups. The human gene HGAL is predominantly expressed in GCs. It is also part of the gene expression signature of GC-like DLBCL, and its high expression in DLBCL has been associated with a better clinical prognosis. We have generated mice deficient of the HGAL homologue M17 in order to investigate its functional significance. The mutant animals form normal GCs, undergo efficient CSR and SHM, and mount T-cell-dependent antibody responses similar to wild-type controls. Thus, M17 is dispensable for the GC reaction, and its potential function in the pathogenesis of DLBCL remains elusive.

Citing Articles

Regulation of BCR-dependent germinal center B-cell formation by HGAL and insight into its emerging myeloid ortholog, C1ORF150.

Toran P, Novelli A, Lazor J, Vachon A, Wojchowski D Front Immunol. 2024; 15:1437516.

PMID: 39474423 PMC: 11518702. DOI: 10.3389/fimmu.2024.1437516.

Memory B cell subsets have divergent developmental origins that are coupled to distinct imprinted epigenetic states.

Callahan D, Smita S, Joachim S, Hoehn K, Kleinstein S, Weisel F Nat Immunol. 2024; 25(3):562-575.

PMID: 38200277 DOI: 10.1038/s41590-023-01721-9.

Sequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria.

Kristjansson R, Oskarsson G, Skuladottir A, Oddsson A, Rognvaldsson S, Sveinbjornsson G Commun Biol. 2023; 6(1):703.

PMID: 37430141 PMC: 10333346. DOI: 10.1038/s42003-023-05079-4.

Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response.

Glaros V, Rauschmeier R, Artemov A, Reinhardt A, Ols S, Emmanouilidi A Immunity. 2021; 54(9):2005-2023.e10.

PMID: 34525339 PMC: 7612941. DOI: 10.1016/j.immuni.2021.08.017.

Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice.

Masle-Farquhar E, Russell A, Li Y, Zhu F, Rui L, Brink R PLoS One. 2021; 16(4):e0237830.

PMID: 33914737 PMC: 8084200. DOI: 10.1371/journal.pone.0237830.

References

Natkunam Y, Lossos I, Taidi B, Zhao S, Lu X, Ding F . Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood. 2005; 105(10):3979-86. PMC: 1895083. DOI: 10.1182/blood-2004-08-3112. View

Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula S, Shen Q . Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell. 2005; 7(5):445-55. DOI: 10.1016/j.ccr.2005.03.037. View

Cariappa A, Mazo I, Chase C, Shi H, Liu H, Li Q . Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes. Immunity. 2005; 23(4):397-407. DOI: 10.1016/j.immuni.2005.09.004. View

Weiss U, Rajewsky K . The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response. J Exp Med. 1990; 172(6):1681-9. PMC: 2188767. DOI: 10.1084/jem.172.6.1681. View

Kuppers R, Klein U, Hansmann M, Rajewsky K . Cellular origin of human B-cell lymphomas. N Engl J Med. 1999; 341(20):1520-9. DOI: 10.1056/NEJM199911113412007. View

Esposito G, Texido G, Betz U, Gu H, Muller W, Klein U . Mice reconstituted with DNA polymerase beta-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their Ig genes normally. Proc Natl Acad Sci U S A. 2000; 97(3):1166-71. PMC: 15557. DOI: 10.1073/pnas.97.3.1166. View

Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403(6769):503-11. DOI: 10.1038/35000501. View

Lossos I, Alizadeh A, Eisen M, Chan W, Brown P, Botstein D . Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A. 2000; 97(18):10209-13. PMC: 27813. DOI: 10.1073/pnas.180316097. View

Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti R, Kuppers R . Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001; 412(6844):341-6. DOI: 10.1038/35085588. View

10.

Lossos I, Jones C, Warnke R, Natkunam Y, Kaizer H, Zehnder J . Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2001; 98(4):945-51. DOI: 10.1182/blood.v98.4.945. View

11.

Kuppers R, Dalla-Favera R . Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001; 20(40):5580-94. DOI: 10.1038/sj.onc.1204640. View

12.

Shipp M, Ross K, Tamayo P, Weng A, Kutok J, Aguiar R . Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002; 8(1):68-74. DOI: 10.1038/nm0102-68. View

13.

Manis J, Tian M, Alt F . Mechanism and control of class-switch recombination. Trends Immunol. 2002; 23(1):31-9. DOI: 10.1016/s1471-4906(01)02111-1. View

14.

Staudt L . Gene expression profiling of lymphoid malignancies. Annu Rev Med. 2002; 53:303-18. DOI: 10.1146/annurev.med.53.082901.103941. View

15.

Rosenwald A, Wright G, Chan W, Connors J, Campo E, Fisher R . The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(25):1937-47. DOI: 10.1056/NEJMoa012914. View

16.

Lossos I, Alizadeh A, Rajapaksa R, Tibshirani R, Levy R . HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood. 2003; 101(2):433-40. DOI: 10.1182/blood-2002-06-1931. View

17.

Schenten D, Gerlach V, Guo C, Velasco-Miguel S, Hladik C, White C . DNA polymerase kappa deficiency does not affect somatic hypermutation in mice. Eur J Immunol. 2003; 32(11):3152-60. DOI: 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2. View

18.

Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt L . Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am J Pathol. 2003; 163(1):135-44. PMC: 1868163. DOI: 10.1016/S0002-9440(10)63637-1. View

19.

Wright G, Tan B, Rosenwald A, Hurt E, Wiestner A, Staudt L . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003; 100(17):9991-6. PMC: 187912. DOI: 10.1073/pnas.1732008100. View

20.

Li Z, Woo C, Iglesias-Ussel M, Ronai D, Scharff M . The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 2004; 18(1):1-11. DOI: 10.1101/gad.1161904. View